Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

1. Diaz, R.
2. Nguewa, P.A.
3. Parrondo, R.
4. Perez-Stable, C.
5. Manrique, I.
6. Redrado, M.
7. Catena, R.
8. Collantes, M.
9. Peñuelas, I.
10. Díaz-González, J.A.
11. Calvo, A.

Export

Export ×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export ×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo lock_openDadun handle

DOI: 10.1186/1471-2407-10-188 GOOGLE SCHOLAR lock_openOpen access editor HANDLE: https://hdl.handle.net/10171/13173

Sustainable development goals

• 

Data source: Scopus